LPL Financial »

Summit Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $287k 16k 17.85
2024-09-30 $365k 17k 21.90

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)

View all positions for LPL Financial

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Millennium Management
Twin Tree Management
Charles Schwab Investment Management
Standard Life Aberdeen
UBS Group
Rock Springs Capital Management
Jane Street
Goldman Sachs Group

View all funds holding Summit Therapeutics